When asked on 4/21/16 about updates for the launch/commencement of the ZEN003694 trial and an update on the closing of the reorganization/arrangement for Zenith Epigenetics Ltd/Zenith Capital Corp, Sarah replied:

"I cannot get into selective disclosure, however I can confirm that an update will be coming via press release."

Previously in Feburary 2016 when asked a similar question, Sarah indicated:

"The company has decided to close the Zenith reorganization after the clinical trial has commenced to avoid any delay to the launch of the trial."

Seems like we could hear something from Zenith any day now since there are 3 study sites now active in the ZEN003694 trial as of 4/30/16.

BearDownAZ